CN104173494B - 一种治疗冠心病的中药制剂 - Google Patents
一种治疗冠心病的中药制剂 Download PDFInfo
- Publication number
- CN104173494B CN104173494B CN201410446834.5A CN201410446834A CN104173494B CN 104173494 B CN104173494 B CN 104173494B CN 201410446834 A CN201410446834 A CN 201410446834A CN 104173494 B CN104173494 B CN 104173494B
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- chinese medicine
- radix
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 47
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 241000218176 Corydalis Species 0.000 claims abstract description 15
- 241000237903 Hirudo Species 0.000 claims abstract description 15
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 14
- 210000000582 semen Anatomy 0.000 claims abstract description 13
- 230000017531 blood circulation Effects 0.000 abstract description 30
- 230000000694 effects Effects 0.000 abstract description 28
- 210000004185 liver Anatomy 0.000 abstract description 28
- 238000011282 treatment Methods 0.000 abstract description 22
- 239000008280 blood Substances 0.000 abstract description 20
- 210000004369 blood Anatomy 0.000 abstract description 20
- 210000000952 spleen Anatomy 0.000 abstract description 19
- 201000010099 disease Diseases 0.000 abstract description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 13
- 230000001737 promoting effect Effects 0.000 abstract description 11
- 206010002383 Angina Pectoris Diseases 0.000 abstract description 10
- 208000002193 Pain Diseases 0.000 abstract description 9
- 230000033228 biological regulation Effects 0.000 abstract description 9
- 239000003146 anticoagulant agent Substances 0.000 abstract description 6
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 210000004204 blood vessel Anatomy 0.000 abstract description 4
- 208000010125 myocardial infarction Diseases 0.000 abstract description 4
- 210000004165 myocardium Anatomy 0.000 abstract description 4
- 231100000862 numbness Toxicity 0.000 abstract description 4
- 230000001502 supplementing effect Effects 0.000 abstract description 4
- 229930194542 Keto Natural products 0.000 abstract description 2
- 230000000702 anti-platelet effect Effects 0.000 abstract description 2
- 230000002785 anti-thrombosis Effects 0.000 abstract description 2
- 229940127219 anticoagulant drug Drugs 0.000 abstract description 2
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 abstract description 2
- 125000000468 ketone group Chemical group 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 abstract 1
- 208000026758 coronary atherosclerosis Diseases 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 11
- 239000003826 tablet Substances 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 210000004351 coronary vessel Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 206010008479 Chest Pain Diseases 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 208000031225 myocardial ischemia Diseases 0.000 description 4
- 238000000034 method Methods 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000012913 prioritisation Methods 0.000 description 3
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 102000007625 Hirudins Human genes 0.000 description 2
- 108010007267 Hirudins Proteins 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 2
- 229940006607 hirudin Drugs 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- 208000004476 Acute Coronary Syndrome Diseases 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 206010065558 Aortic arteriosclerosis Diseases 0.000 description 1
- 206010003225 Arteriospasm coronary Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000003890 Coronary Vasospasm Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 201000001962 aortic atherosclerosis Diseases 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 201000011634 coronary artery vasospasm Diseases 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001709 ictal effect Effects 0.000 description 1
- 230000001965 increasing effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
- 229960002237 metoprolol Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000001196 vasorelaxation Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 例数 | 治愈n(%) | 显效n(%) | 有效n(%) | 无效n(%) | 总有效率n(%) |
对照组 | 150 | 60(40.0) | 122(81.3) | 133(88.7) | 17(11.3) | 133(88.7) |
治疗组 | 150 | 137(91.3) | 146(97.3) | 149(99.3) | 1(0.7) | 149(99.3) |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410446834.5A CN104173494B (zh) | 2014-09-04 | 2014-09-04 | 一种治疗冠心病的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410446834.5A CN104173494B (zh) | 2014-09-04 | 2014-09-04 | 一种治疗冠心病的中药制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104173494A CN104173494A (zh) | 2014-12-03 |
CN104173494B true CN104173494B (zh) | 2016-08-24 |
Family
ID=51955018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410446834.5A Expired - Fee Related CN104173494B (zh) | 2014-09-04 | 2014-09-04 | 一种治疗冠心病的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104173494B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106166215A (zh) * | 2016-09-26 | 2016-11-30 | 秦敬华 | 一种治疗心脑血管病的中药组合物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102302552A (zh) * | 2011-08-31 | 2012-01-04 | 朱明军 | 一种治疗心律失常的胶囊及其制备方法 |
-
2014
- 2014-09-04 CN CN201410446834.5A patent/CN104173494B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102302552A (zh) * | 2011-08-31 | 2012-01-04 | 朱明军 | 一种治疗心律失常的胶囊及其制备方法 |
Non-Patent Citations (2)
Title |
---|
中西医结合治疗冠心病心绞痛43例;毛秉豫等;《国医论坛》;19961231;第11卷(第5期);第25页-26页,尤其是第2.1节治疗方法 * |
冠心病心绞痛从肝论治体会;杨森等;《河南中医》;20050131;第25卷(第1期);第47页,尤其是第1.3-1.5节 * |
Also Published As
Publication number | Publication date |
---|---|
CN104173494A (zh) | 2014-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102357187B (zh) | 一种治疗急性腰扭伤的中药组合物 | |
CN101716242B (zh) | 一种治疗心脑血管疾病的中药 | |
CN101095768B (zh) | 一种治疗中老年原发性高血压的中药胶囊 | |
CN110585413A (zh) | 治疗小儿感冒咳嗽、腹痛腹泻的中药贴敷膏及其制备方法 | |
CN102114231B (zh) | 一种治疗心律失常的药物 | |
CN103432559A (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN104069446A (zh) | 一种治疗冠心病心绞痛的中药组合物 | |
CN103919910A (zh) | 一种治疗冠心病的药物 | |
CN104645249B (zh) | 一种治疗冠心病心绞痛的药物 | |
CN102657795A (zh) | 一种促进术后刀口愈合的中药制剂 | |
CN104173494B (zh) | 一种治疗冠心病的中药制剂 | |
CN103212041B (zh) | 一种治疗冠心病的中药组合物 | |
CN106421639A (zh) | 一种治疗心脑血管疾病的中药 | |
CN103212044B (zh) | 一种治疗心血管疾病的中药组合物 | |
CN104800772A (zh) | 一种治疗气郁型冠心病的中药组合物及应用 | |
CN102652822A (zh) | 一种治疗冠心病的中药口服液 | |
CN101569708B (zh) | 一种治疗缺血性心脏病的药物及其制备方法 | |
CN101983712A (zh) | 冠心病的新型治疗药物 | |
CN106074784A (zh) | 治疗冠心病心肌缺血的中药 | |
CN106822852A (zh) | 治疗冠心病的药物组合物、其制备工艺及用途 | |
CN104840929A (zh) | 一种治疗冠心病的中药蜜丸 | |
CN105456538A (zh) | 治疗骨质疏松的药物 | |
CN102641420A (zh) | 一种治疗冠心病的药物组合物 | |
CN104758888A (zh) | 一种治疗消渴病的中药组合物 | |
CN103656554A (zh) | 一种治疗肿瘤、癌症的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Hu Qing Inventor before: Lu Zhengliang Inventor before: Wang Min |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160706 Address after: 402, room 3, unit 10, building 9, Tongxin Road, Yingbin Road, Shandong, Zoucheng 273500, China Applicant after: Hu Qing Address before: 266200, 201, 1, building 17, 180 Zhenhua street, Jimo, Shandong, Qingdao Applicant before: Lu Zhengliang |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Yuxia Inventor after: Xiao Jing Inventor before: Hu Qing |
|
CB03 | Change of inventor or designer information | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171201 Address after: Los Angeles street lijiacun 262700 Shandong city in Weifang Province, Shouguang City, No. 57 Patentee after: Liu Yuxia Address before: 402, room 3, unit 10, building 9, Tongxin Road, Yingbin Road, Shandong, Zoucheng 273500, China Patentee before: Hu Qing |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160824 Termination date: 20170904 |
|
CF01 | Termination of patent right due to non-payment of annual fee |